Are we too lenient with immunosuppression in severe cases of Systemic Sclerosis?
Rheumatology (Oxford)
.
2016 Oct;55(10):1914-6.
doi: 10.1093/rheumatology/kew242.
Epub 2016 Jun 21.
Authors
Elise Siegert
1
,
Gabriela Riemekasten
2
Affiliations
1
Department of Rheumatology and Clinical Immunology, Charité - University Medicine Berlin, Berlin.
2
Department of Rheumatology, University Medical Center Schleswig-Holstein, Lübeck, Germany gabriela.riemekasten@uksh.de.
PMID:
27330162
DOI:
10.1093/rheumatology/kew242
No abstract available
Publication types
Review
MeSH terms
Humans
Immune Tolerance*
Immunosuppression Therapy / methods*
Immunosuppressive Agents / therapeutic use*
Scleroderma, Systemic* / diagnosis
Scleroderma, Systemic* / drug therapy
Scleroderma, Systemic* / immunology
Substances
Immunosuppressive Agents